A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation

Abstract Background Essential thrombocythemia (ET) is a rare cause of stroke. The V617F mutation in the Janus kinase 2 (JAK2) gene is one of the most typical mutations in ET and has been shown to be a risk factor for stroke, especially in younger people. However, to date, there have been few reports...

Full description

Bibliographic Details
Main Authors: Ran Yan, Donghua Mi, Xin Qiu, Zixiao Li
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-022-02964-z
_version_ 1797984062982324224
author Ran Yan
Donghua Mi
Xin Qiu
Zixiao Li
author_facet Ran Yan
Donghua Mi
Xin Qiu
Zixiao Li
author_sort Ran Yan
collection DOAJ
description Abstract Background Essential thrombocythemia (ET) is a rare cause of stroke. The V617F mutation in the Janus kinase 2 (JAK2) gene is one of the most typical mutations in ET and has been shown to be a risk factor for stroke, especially in younger people. However, to date, there have been few reports of intracranial thrombotic and hemorrhagic complications in patients with ET. Herein, we present a case of JAK2 gene mutation-associated ET in a patient who developed both ischemic and hemorrhagic stroke, and discuss potential underlying mechanisms. Case presentation A 45-year-old Chinese male presented to our center with gradually developing weakness of the right limbs for 3 months. A computed tomography scan of the brain showed an area of infarction with hemorrhage in the left subcortical and corona radiata regions. High-resolution magnetic resonance imaging revealed a thrombosis on the surface of the atherosclerotic plaque. Digital subtraction angiography revealed an insect bite-like change in the C1 branch of the left internal carotid artery, which caused up to 50% stenosis. Blood tests showed continued elevation of the platelet and white blood cell counts. After consultation with a hematologist, a bone marrow biopsy was performed, which revealed proliferative bone marrow changes with numerous megakaryocytes and proliferative but mature granulocytes. Further genetic testing revealed a positive JAK2-V617F mutation. Therefore, the diagnosis of ET was confirmed according to the World Health Organization (WHO) 2016 diagnostic criteria. Finally, we decided to administer aspirin and hydroxyurea. The patient remained stroke free and the platelet levels were normal throughout the 1-year follow-up period. Conclusions JAK2 mutations affect the proliferation and differentiation of blood cells through the JAK, signal transducer and activator of transcription pathway, which leads to changes in platelets and macrophages, and an increase in neutrophil extracellular traps, which may explain the patient’s ischemic and hemorrhagic changes. Further investigation of the underlying mechanisms may change the treatment strategy for such patients in the future.
first_indexed 2024-04-11T06:56:40Z
format Article
id doaj.art-5a56a362b9ab4800b7c938c5985ba51d
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-11T06:56:40Z
publishDate 2022-11-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-5a56a362b9ab4800b7c938c5985ba51d2022-12-22T04:39:01ZengBMCBMC Neurology1471-23772022-11-012211510.1186/s12883-022-02964-zA case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutationRan Yan0Donghua Mi1Xin Qiu2Zixiao Li3Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityVascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityVascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityVascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityAbstract Background Essential thrombocythemia (ET) is a rare cause of stroke. The V617F mutation in the Janus kinase 2 (JAK2) gene is one of the most typical mutations in ET and has been shown to be a risk factor for stroke, especially in younger people. However, to date, there have been few reports of intracranial thrombotic and hemorrhagic complications in patients with ET. Herein, we present a case of JAK2 gene mutation-associated ET in a patient who developed both ischemic and hemorrhagic stroke, and discuss potential underlying mechanisms. Case presentation A 45-year-old Chinese male presented to our center with gradually developing weakness of the right limbs for 3 months. A computed tomography scan of the brain showed an area of infarction with hemorrhage in the left subcortical and corona radiata regions. High-resolution magnetic resonance imaging revealed a thrombosis on the surface of the atherosclerotic plaque. Digital subtraction angiography revealed an insect bite-like change in the C1 branch of the left internal carotid artery, which caused up to 50% stenosis. Blood tests showed continued elevation of the platelet and white blood cell counts. After consultation with a hematologist, a bone marrow biopsy was performed, which revealed proliferative bone marrow changes with numerous megakaryocytes and proliferative but mature granulocytes. Further genetic testing revealed a positive JAK2-V617F mutation. Therefore, the diagnosis of ET was confirmed according to the World Health Organization (WHO) 2016 diagnostic criteria. Finally, we decided to administer aspirin and hydroxyurea. The patient remained stroke free and the platelet levels were normal throughout the 1-year follow-up period. Conclusions JAK2 mutations affect the proliferation and differentiation of blood cells through the JAK, signal transducer and activator of transcription pathway, which leads to changes in platelets and macrophages, and an increase in neutrophil extracellular traps, which may explain the patient’s ischemic and hemorrhagic changes. Further investigation of the underlying mechanisms may change the treatment strategy for such patients in the future.https://doi.org/10.1186/s12883-022-02964-zIschemic strokeHemorrhagic transformationJAK2 mutationEssential thrombocythemia
spellingShingle Ran Yan
Donghua Mi
Xin Qiu
Zixiao Li
A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
BMC Neurology
Ischemic stroke
Hemorrhagic transformation
JAK2 mutation
Essential thrombocythemia
title A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
title_full A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
title_fullStr A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
title_full_unstemmed A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
title_short A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
title_sort case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and jak 2 v617f mutation
topic Ischemic stroke
Hemorrhagic transformation
JAK2 mutation
Essential thrombocythemia
url https://doi.org/10.1186/s12883-022-02964-z
work_keys_str_mv AT ranyan acaseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT donghuami acaseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT xinqiu acaseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT zixiaoli acaseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT ranyan caseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT donghuami caseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT xinqiu caseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation
AT zixiaoli caseofischemicstrokewithhemorrhagictransformationassociatedwithessentialthrombocythemiaandjak2v617fmutation